Clinical and experimental uses of umbilical cord blood

Internal Medicine Journal

Volumn 32, Issue 12, 2002, Pages 601-609

  Lewis, Ian D ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Cord blood; Ex vivo expansion; Graft vs. host disease; Leukaemia; Transplantation

Indexed keywords

CHILD; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IN VIVO STUDY; LEUKEMIA; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VIRUS TRANSMISSION; ADULT; AUSTRALIA; BLOOD BANK; CELL CULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; METHODOLOGY; STATISTICS;

ADULT; AUSTRALIA; BLOOD BANKS; CELLS, CULTURED; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; TREATMENT OUTCOME;

EID: 0036984984     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00276.x     Document Type: Review

References (49)

1. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-8.
2. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157-66.
3. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795-802.
4. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-77.
5. Gluckman E. Current status of umbilical cord blood hematopoietic stem-cell transplantation. Exp Hematol 2000; 28: 1197-205.
6. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord - Cord Blood Transplant Group. Blood 1999; 93: 3662-71.
7. Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood 2000; 96: 4096-102.
8. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
9. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247-56.
10. Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C et al. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354-63.
11. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-71.
12. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957-61.
13. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-22.
14. Hongeng S, Krance RA, Bowman LC, Srivastava DK, Cunningham JM, Horwitz EM et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 350: 767-71.
15. Gustafsson A, Remberger M, Winiarski J, Ringden O. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transplant 2000; 25: 1059-65.
16. Cairo MS, Law P, van de Ven C, Plunkett JM, Williams D, Ishizawa L et al. The in vitro effects of stem cell factor and PIXY321 on myeloid progenitor formation (CFU-GM) from immunomagnetic separated CD34+ cord blood. Pediatr Res 1992; 32: 277-81.
17. Lu L, Wang LS, Cooper RJ, Liu HJ, Turner K, Weich N et al. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow. J Hematother Stem Cell Res 2000; 9: 195-204.
18. Lu L, Xiao M, Shen RN, Grigsby S, Broxmeyer HE. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993; 81: 41-8.
19. Hows JM, Bradley BA, Marsh JC, Luft T, Coutinho L, Testa NG et al. Growth of human umbilical-cord blood in longterm haemopoietic cultures. Lancet 1992; 340: 73-6.
20. Lewis ID, Verfaillie CM. Multi-lineage expansion potential of primitive hematopoietic progenitors. Superiority of umbilical cord blood compared to mobilized peripheral blood. Exp Hematol 2000; 28: 1087-95.
21. Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994; 83: 2489-97.
22. Cohen SB, Madrigal JA. Immunological and functional differences between cord and peripheral blood. Bone Marrow Transplant 1998; 21: S9-12.
23. Macardle PJ, Wheatland L, Zola H. Analysis of the cord blood T lymphocyte response to superantigen. Hum Immunol 1999; 60: 127-39.
24. Risdon G, Gaddy J, Horie M, Broxmeyer HE. Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA 1995; 92: 2413-7.
25. Takahashi N, Imanishi K, Nishida H, Uchiyama T. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol 1995; 155: 5213-9.
26. Harris DT, LoCascio J, Besencon FJ. Analysis of the alloreactive capacity of human umbilical cord blood: Implications for graft-versus-host disease. Bone Marrow Transplant 1994; 14: 545-53.
27. Harris DT. Cord blood transplantation: implications for graft vs. host disease and graft vs. leukemia. Blood Cells 1994; 20: 560-4.
28. Gaddy J, Risdon G, Broxmeyer HE. Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interferon Cytokine Res 1995; 15: 527-36.
29. Cohen SB, Morgan CL, Perez-Cruz I, Perandin F, Martinez B, Madrigal JA. Cord blood serum does not increase lymphocyte responses in comparison to adult serum. Hum Immunol 2000; 61: 111-4.
30. Giraud P, Thuret I, Reviron D, Chambost H, Brunet C, Novakovitch G et al. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplant 2000; 25: 53-7.
31. Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703-11.
32. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001; 344: 1870-1.
33. Itoh K, Tezuka H, Sakoda H, Konno M, Nagata K, Uchiyama T et al. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol 1989; 17: 145-53.
34. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 1991; 78: 666-72.
35. Brandt JE, Bartholomew AM, Fortman JD, Nelson MC, Bruno E, Chen LM et al. Ex vivo expansion of autologous bone marrow CD34 (+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood 1999; 94: 106-13.
36. Shih CC, Hu MC, Hu J, Medeiros J, Forman SJ. Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood 1999; 94: 1623-36.
37. Lewis ID, Almeida-Porada GJ, Du J, Lemischka IR, Moore KA, Zanjani ED et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001; 97: 3441-9.
38. Bhatia M, Bonnet D, Kapp U, Wang JCY, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997; 186: 619-24.
39. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 1997; 94: 9836-41.
40. Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B et al. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34 (+) cord blood cells. Exp Hematol 2000; 28: 1470-80.
41. Reiffers J, Cailliot C, Dazey B, Attal M, Caraux J, Boiron JM. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD34-positive cells. Lancet 1999; 354: 1092-3.
42. McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001-7.
43. Paquette RL, Dergham ST, Karpf E, Wang HJ, Slamon DJ, Souza L et al. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 2000; 96: 2385-90.
44. Shpall EJ, Quinones R, Jones R, Bearman SI, Cagnoni P, Giller R et al. Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo. Blood 1999; 94: 712a.
45. McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 2000; 28: 1181-6.
46. Pitcher LA, Teague L, Shaw PJ, Nivison-Smith I, Tiedemarm K, Vowels M et al. Outcome of unrelated donor cord blood transplants (URD UCBT) in Australia and New Zealand - an ANZCCSG and ABMTRR study. Blood 2000; 96: 363b.
47. Ballen KK, Wilson M, Wuu J, Ceredona AM, Hsieh C, Stewart FM et al. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant 2001; 27: 7-14.
48. Stanworth S, Warwick R, Fehily D, Persaud C, Armitage S, Navarrete C et al. An international survey of unrelated umbilical cord blood banking. Vox Sang 2001; 80: 236-43.
49. Gluckman E, Rocha V, Chastang C. Cord blood banking and transplant in Europe. Eurocord Vox Sang 1998; 74: 95-101.